End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
60.3 TWD | +2.20% | +10.24% | +19.88% |
03-11 | TSH Biopharm Corporation Limited Announces Directorate Changes on April 1, 2024 | CI |
03-11 | TSH Biopharm Corporation Limited Appoints Jung-Liang Kao as CFO on April 1, 2024 | CI |
Sales 2022 | 464M 14.25M 1.14B | Sales 2023 | 811M 24.89M 1.99B | Capitalization | 1.93B 59.29M 4.74B |
---|---|---|---|---|---|
Net income 2022 | 61M 1.87M 150M | Net income 2023 | 62M 1.9M 152M | EV / Sales 2022 | 2.38 x |
Net cash position 2022 | 722M 22.17M 1.77B | Net cash position 2023 | 765M 23.47M 1.88B | EV / Sales 2023 | 1.44 x |
P/E ratio 2022 |
29.5
x | P/E ratio 2023 |
31.2
x | Employees | 76 |
Yield 2022 |
3.36% | Yield 2023 |
2.54% | Free-Float | 35.47% |
1 day | +2.20% | ||
1 week | +10.24% | ||
Current month | +5.42% | ||
1 month | +6.91% | ||
3 months | +20.60% | ||
6 months | +32.53% | ||
Current year | +19.88% |
Managers | Title | Age | Since |
---|---|---|---|
Ssu Yuan Yang
CEO | Chief Executive Officer | - | - |
Chen Ju Kan
DFI | Director of Finance/CFO | - | 31/08/10 |
Shu Ping Huang
ADM | Chief Administrative Officer | - | 31/08/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kang Chi Chou
BRD | Director/Board Member | - | - |
Chuan Lin
CHM | Chairman | 72 | - |
Hsin Yang Liu
PRN | Corporate Officer/Principal | - | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 60.3 | +2.20% | 279,007 |
25/04/24 | 59 | -0.84% | 175,652 |
24/04/24 | 59.5 | -1.98% | 228,936 |
23/04/24 | 60.7 | +7.05% | 513,919 |
22/04/24 | 56.7 | +3.66% | 226,509 |
End-of-day quote Taipei Exchange, April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+19.88% | 70.98M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 8432 Stock